Navigation Links
Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
Date:9/3/2009

NEW YORK, Sept. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Botanical and Plant-Derived Drugs: Global Markets

http://www.reportlinker.com/p0118047/Botanical-and-Plant-Derived-Drugs-Global-Markets.html

This report:

  • Identifies and classifies the plant-derived drugs that have been commercialized to date
  • Contains forecasts for the global volume and value of plant-derived drug shipments and their markets through 2013
  • Analyzes the historical and current volume and value of shipments of each of these drugs in specified geographical markets
  • Identifies and evaluates the impact of factors that will drive future demand for plant-derived drugs
  • Describes plant-derived drugs that are currently in the clinical testing or approvals stage and assesses the probability that they will be commercialized successfully in the next 5 years
  • Profiles the leading manufacturers of plant-derived drugs and the firms that may become important players in the next 5 years.

CHAPTER 1: INTRODUCTION

STUDY BACKGROUND

STUDY GOAL AND OBJECTIVES

INTENDED AUDIENCE

SCOPE OF REPORT

METHODOLOGY AND INFORMATION SOURCES

COMMERCIAL DRUGS

DEVELOPMENTAL DRUGS

TABLE 1 FDA APPROVAL PROCESS FOR NEW DRUGS

ANALYST CREDENTIALS

RELATED BCC PUBLICATIONS

BCC ONLINE SERVICES

DISCLAIMER

CHAPTER 2: SUMMARY

SUMMARY TABLE GLOBAL FORECAST FOR BOTANICAL* AND PLANT-DERIVED DRUGS, THROUGH 2013 ($ BILLIONS)

SUMMARY FIGURE GLOBAL FORECAST FOR BOTANICAL* AND PLANT-DERIVED DRUGS, THROUGH 2013 ($ BILLIONS)

CHAPTER 3: OVERVIEW

BRIEF HISTORY OF PLANT-DERIVED MEDICINES

BRIEF HISTORY OF PLANT-. . . (CONTINUED)

TABLE 2 KEY DATES IN BOTANICAL MEDICINE

TABLE 3 WELL KNOWN PLANT-DERIVED DRUGS

OPPORTUNITY LIES BEYOND WHAT'S KNOWN

FIGURE 1 COMPOSITION OF FDA-APPROVED NATURAL-DERIVED COMPOUNDS IN U.S. (2000-2005)* (%)

KEY DRIVERS

KEY CHALLENGES

SIGNS OF INDUSTRY INVESTMENT

TABLE 4 SWOT ANALYSIS ON BOTANICAL DRUG DEVELOPMENT

TABLE 5 KEY SIGNS OF INVESTMENT IN BOTANICAL AND OTHER PLANT-DERIVED DRUGS

BOTANICAL DRUGS DEFINED

UNDERSTANDING THE REGULATORY PROCESS

TABLE 6 DISTINCTIONS AMONG PRODUCTS THAT USE PLANTS MEDICINALLY

THE FIRST APPROVED BOTANICAL

A GROWING PIPELINE

FIGURE 2 INDS IN THE FDA BY THERAPEUTIC AREA (NUMBER)

OVERALL PHARMA LANDSCAPE

TABLE 7 TOP PHARMA COMPANIES BY REVENUE, 2007 ($ BILLIONS)

MAJOR CLASSES OF PLANT DRUGS

Terpenes and Steroids

Terpenes

Steroids

Alkaloids and Glycosides

Alkaloids

Ergot Alkaloids

Morphine Alkaloids

Vinca Alkaloids

Glycosides

Cardiac Glycosides

Anthraglycosides

Phenols

E. Cava Algae

Flavonoids

Resveratrol

Coumarin

Catechins

Proanthocyanidins

INTELLECTUAL PROPERTY

PRODUCTION

MOVING PRODUCTION FORWARD

ARTEMISININ: A CASE STUDY

SUPPLY AND LEGAL ISSUES

TABLE 8 MAJOR PRODUCERS OF RAW MATERIALS FOR PLANT-BASED MEDICINALS

DRUG DEVELOPMENT AND MANUFACTURE

TABLE 9 KEY COMPANIES WITH NATURAL PRODUCT LIBRARIES

CHAPTER 4: MARKET SEGMENTATION

GEOGRAPHIC SEGMENTATION

SALES OF PLANT-DERIVED DRUGS BY REGION

TABLE 10 PLANT-DERIVED DRUG SALES FORECAST BY REGION, THROUGH 2013 (% TOTAL SALES)

FIGURE 3 GEOGRAPHIC SEGMENTATION FOR PLANT-DERIVED DRUGS, 2008 AND 2013 (%)

THERAPEUTIC AREA SEGMENTATION

NUMBER OF PLANT-DERIVED DRUGS BY THERAPEUTIC AREA

TABLE 11 FDA APPROVED BOTANICAL DRUGS FORECAST THROUGH 2013 (UNITS)

FIGURE 4 COMPOSITION OF FDA APPROVED BOTANICAL INDICATION FORECAST BY THERAPEUTIC AREA, 2008 AND 2013 (%)*

Value of Plant-Derived Drugs by Therapeutic Area

TABLE 12 RELATIVE VALUES OF FDA APPROVED BOTANICAL DRUGS FORECAST BY THERAPUETIC AREA, THROUGH 2013 ($ MILLIONS)

FIGURE 5 RELATIVE VALUES OF FDA APPROVED BOTANICAL DRUGS FORECAST BY THERAPEUTIC AREA, 2008 AND 2013 (%)

CHAPTER 5: THERAPEUTIC AREAS IN DETAIL FOR PLANT-DERIVED AND BOTANICAL DRUGS, THROUGH 2013

HORMONE THERAPY AND

To order this report:

Botanical and Plant-Derived Drugs: Global Markets

http://www.reportlinker.com/p0118047/Botanical-and-Plant-Derived-Drugs-Global-Markets.html

More market research reports here!

Contact

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Reportlinker Adds Pediatric Health Care Products and Services Report
2. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
3. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
4. Reportlinker Adds Commercial Amino Acids Report
5. Reportlinker Adds Antiseptics and Disinfectants Report
6. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
7. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
8. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
9. Introducing solixir(TM)... The First All-Natural Sparkling Botanical Beverage to Hydrate Body and Soul
10. Desire for Performance Coupled With Natural Ingredients Boosts Botanical Actives Consumption in Personal Care
11. Tea Dragon Films is First Adopter in the American Botanical Councils New Adopt-An-Herb Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... ... Center for Autism and Related Disorders (CARD) Portland today announced plans to ... and other developmental disabilities. The group, which is being launched with the help of ... to share stories and advice, seek help, and continue their education on how to ...
(Date:12/2/2016)... ... December 02, 2016 , ... Dr. ... will be included in the 2016 “Guide to America’s Top Plastic Surgeons” for ... the amalgamation of their education, experience, and professional associations. , One the ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... diagnostic imaging systems and the first company to offer robotic imaging to ... at their tradeshow booth # 941 for the American Association of Equine Practitioners ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health ... has raised $6.0 million in an initial round of funding. The round was ... and their caregivers can receive far better care through the application of the ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... announce that we have been designated as a Cigna Infertility Center of Excellence. ... rigorous performance standards. , “It’s an honor to be designated a Cigna ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... Research and Markets has announced the addition of ... Markets and Companies" to their offering. ... , , ... The market value of drug delivery technologies and the anticancer drugs ... according to organs involved and the types of cancer as well ...
(Date:12/2/2016)... Conn. , Dec. 1, 2016  Today, Simpson ... announced the honor of being selected as winners of ... Simpson Healthcare Executives Website at the PLATINUM level, Blue ... Training Module at the GOLD Level, and our proprietary ... At Simpson Healthcare Executives, we are excited to ...
(Date:12/2/2016)... Dec. 2, 2016  UCB is pleased to announce that 12 ... upcoming 70 th American Epilepsy Society (AES) Annual Meeting, ... TX , USA. 1-12 Data ... profile of VIMPAT ® (lacosamide) CV and BRIVIACT ® ... on the current state of the union of epilepsy care ...
Breaking Medicine Technology: